Teva, Active Biotech plan third MS drug trial
JERUSALEM — Drug makers Teva Pharmaceutical Industries and Active Biotech will start a third late-stage clinical trial of an experimental drug for treating multiple sclerosis, the companies said Wednesday.
Israel-based Teva and Sweden-based Active Biotech said they would start a phase-3 trial of laquinimod for relapsing-remitting multiple sclerosis, also known as RRMS, following an agreement with the Food and Drug Administration.
"The results achieved in the previous phase-3 trials of laquinimod support the clinical utility of this compound as a unique treatment option for multiple sclerosis," Teva president of global research and development and chief scientific officer Michael Hayden said. "We are encouraged by the FDA’s agreement on the trial design and planned analysis and look forward to further developing laquinimod as a potential treatment option for RRMS patients."
The trial, dubbed "CONCERTO," will evaluate the once-daily oral drug in the 0.6-mg and 1.2-mg doses, enrolling about 1,800 patients for up to 24 months.
Yoplait Greek 100 makes market debut
MINNEAPOLIS — Yoplait has introduced a 100-calorie strained Greek yogurt.
Yoplait Greek 100 is fat free and contains twice the amount of protein when compared with regular yogurt, Yoplait said. Packed in 5.3-oz. cups, the yogurt is available in such flavors as strawberry, black cherry, mixed berry, vanilla, peach and key lime.
"Greek yogurt has everything people are looking for in a snack, but sometimes, the calories can add up for those watching their intake," Yoplait Greek 100 marketing manager Liza Dopp said. "We’ve heard from calorie conscious consumers that there is a need for Greek yogurts with less than 150 calories, and we’re thrilled that Yoplait Greek 100 can answer that call."
Yoplait Greek 100 will be available nationwide this month for a suggested retail price of $1.29 per single-serve cup.
M-Edge introduces new BTS items
ODENTON, Md. — M-Edge is gearing up for back to school with its latest items.
The company said its SuperStylus, which retails for $19.99, is a wide-grip stylus features an ergonomic grip and precise touch to make using a touchscreen device easy for students of any age, the company said. Also new is the SuperShell series of cases that are made with ultra-protective closed-cell foam and high-impact corners and are compatible with such devices as iPhone 4/4S, iPad 2 and 3, and Kindle Fire. The series carries a suggested retail price range from $29.99 to $34.99.
M-Edge products are available at retailers nationwide, including Best Buy, Staples, Target and Walmart, as well as Medgestore.com.